Viewing nowCombinationEmpagliflozin and Metformin Prolonged-Release Tablet 5/1000 mg (Empagliflozin, Metformin)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.

MFDS item code 202501722 · Approved 2025.07.09 · Insurance code 642507890
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to assist in blood sugar control in adult patients with type 2 diabetes by combining empagliflozin and metformin. It is taken as an adjunct to diet and exercise therapy to effectively manage blood sugar levels. It is particularly suitable for patients whose blood sugar is not sufficiently controlled, and caution is needed in patients with cardiovascular diseases due to the risk of cardiovascular events. This medication helps improve blood sugar control in patients with type 2 diabetes and aids in the prevention of complications.
The dose of this drug for antidiabetic therapy should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25mg and metformin hydrochloride extended-release 2000 mg. This drug should be taken once daily with the evening meal to reduce gastrointestinal adverse reactions caused by metformin. To reduce gastrointestinal adverse reactions associated with metformin use, the dose of metformin hydrochloride should be increased gradually. Patients taking this drug 10/1000 mg extended-release tablets or 25/1000 mg extended-release tablets should take 1 tablet once daily. Patients taking this drug 5/1000 mg extended-release tablets or 12.5/1000 mg extended-release tablets should take 2 tablets at the same time once daily. To maintain the extended-release properties, this drug should be swallowed whole and not split, crushed, ground, or chewed. This drug may not dissolve completely and may be excreted in the stool. It is not known whether the material excreted in the stool contains the active ingredients of the drug. If a patient repeatedly reports finding this drug in the stool, healthcare professionals should assess whether blood glucose is being adequately controlled (see Precautions, 5. General Precautions). For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended initial total daily dose when taking this drug is empagliflozin 10 mg and the patient's current metformin dose. If empagliflozin 10 mg is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg. Patients switching from combination therapy with empagliflozin and metformin to this drug should receive their current doses of empagliflozin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and dosage adjustments made as appropriate. When this drug is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions, 4. Adverse Reactions and 6. Interactions). Because dose adjustment may be required based on renal function, assessment of renal function is recommended before starting this drug and periodically during treatment. No dosage adjustment of this drug is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73m2 and <60 mL/min/1.73m2] who tolerate treatment well and have no other conditions that may increase the risk of lactic acidosis, this drug may be used with adjustment of the metformin hydrochloride dose as follows: - Since the starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, treatment should not be initiated with this drug. The maximum daily dose of metformin hydrochloride is 1000 mg. If creatinine clearance (CrCl) decreases to <45 ml/min or estimated glomerular filtration rate (eGFR) decreases to <45 ml/min/1.73m2, this drug should be discontinued immediately. For patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication is used for the treatment of diabetes, with the main ingredients being empagliflozin and metformin. Caution is required when taking this medication as it can cause a rare side effect called lactic acidosis. Lactic acidosis is a serious condition caused by excessive buildup of lactic acid in the blood, symptoms of which may include vomiting, abdominal pain, muscle pain, and shortness of breath. Additionally, if taken with other diabetes medications, hypoglycemia symptoms may occur, so blood sugar levels should be monitored closely. This medication should not be taken by patients with moderate to severe renal impairment or acute renal injury. Regular monitoring of renal function is important. Discontinuation of this medication is necessary in cases of acute infection, dehydration, pre- and post-surgical situations, heart failure, or other serious health conditions, and it can be restarted once health improves. This medication may increase the risk of genital and urinary tract infections, so immediate consultation with healthcare professionals is advised if any infection symptoms appear. The metformin component may lower vitamin B12 levels, so it is advisable to check vitamin B12 levels regularly during long-term use. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. Elderly patients, especially those over 75 years of age, should be especially cautious due to higher risks of fluid loss and renal impairment. Tablets should not be broken, crushed, or chewed, and should be swallowed whole; it is normal for the tablet coating to be excreted in the stool. In the event of overdose, there is a risk of hypoglycemia or lactic acidosis, so it is important to adhere to the prescribed dosage and notify healthcare providers immediately if any abnormal symptoms occur. It is advisable to avoid alcohol consumption while taking this medication, and blood sugar and renal function should be monitored regularly. Finally, this medication can interact with several other drugs, so it is essential to inform healthcare providers of any other medications being taken.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. The recommended storage temperature is at room temperature between 1°C and 30°C. This helps maintain the efficacy and safety of the medication.
Gray, convex, oval-shaped prolonged-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.